Amara Therapeutics DTIF Funding Success
The Disruptive Technologies Innovation Fund, a major driver of Impact 2030 research and innovation strategy, has awarded Amara Therapeutics funding for RiSolve - a safe and effective personalised therapy that will disrupt the overactive bladder treatment market using an innovative artificial intelligence-based digital platform.
Read the Departmental Press Release
Read more on Silicon Republic
Recent News
Our Values
RESPECT
As it is difficult to seek help for incontinence, we aim to build relationships with our patients based on honesty, empathy and respect.
EMPOWERMENT
Our goal is to inspire confidence in body and mind. We enable women to understand and take control of their condition.
COMMUNITY
We strive to support patients and create a sense of belonging, so women don’t suffer alone and in-silence.
INTEGRITY
We work with experts and patients to provide innovative, evidence-based care pathways aligned with clinical guidelines.
Get In Touch
